Tryptamine names global pharmaceutical leader as chairman
2 Articles
2 Articles
Brompton names new chairman of the board - Installation
Brompton Technology has announced the appointment of Steve Leyland as its new chairman of the board. Leyland’s appointment follows the resignation of Brompton’s previous chairman, Neil Gaydon, for health reasons. A seasoned executive, Leyland brings with him decades of international leadership experience, including senior roles at Barco, Polycom, and Intel. Leyland currently runs a consulting practice advising technology companies and investors …
Tryptamine names global pharmaceutical leader as chairman
Global pharmaceutical leader Herwig Janssen appointed Tryptamine non-executive chairman Janssen held senior leadership roles with multinational pharmaceutical company Johnson & Johnson Chris Ntoumenopoulos will transition to role of executive director Special Report: Psychedelic drug developer Tryptamine Therapeutics has appointed a global pharmaceutical leader as its new chairman and made targeted board changes to strengthen leadership ahead …
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage